New R21 Awarded to DC CFAR Investigators: "Pathways Modulating Memory-like Properties in NK Cells and their Impact on HIV Control" |
|
Please join us in congratulating DC CFAR Basic Science Core Co-Director and Cure SWG Co-Lead Dr. Alberto Bosque (PI, GW), HIV Cure SWG Lead Dr. Rebecca Lynch (Co-I, GW) and DC CFAR Investigator Dr. Katherine Chiappinelli (Co-I, GW) on their recent award of an R21 from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) entitled " Pathways modulating memory-like properties in NK cells and their impact on HIV control". This study will investigate the mechanisms and signaling pathways that promote the generation of memory-like Natural Killer (NK) cells and their implication for therapeutic strategies and vaccine development for HIV.
Click here for more information.
|
|
Are You Participating in USCHA 2022? Help the DC CFAR Spread the News! |
Are you presenting during the upcoming virtual 2022 US Conference on HIV/AIDS (USCHA)? Please let us know if you have had an abstract accepted. We would like to share this good news with your fellow DC CFAR investigators, including those who will also participate in USCHA 2022. Please send the name of the presenting author and the title of the accepted abstract to cfarindc@gmail.com.
Click here for more information.
|
|
New R01 Awarded to DC CFAR Investigator Dr. Xiong Jiang |
The project "aims to quantitatively assess frontostriatal injury in people with HIV using advanced functional MRI (fMRI) techniques". This project is a continuation of the work from Dr. Jiang's R56 with the same title. Dr. Jiang is a previous DC CFAR Pilot Award recipient.
Click here for more information.
|
|
|
Register to Join the DC CFAR Developmental Core Journal Club |
Please join us for a DC CFAR Developmental Core Journal Club Webinar on Monday, September 19 from 12:00 - 1:00 pm ET featuring Infectious Diseases Physician at the Veterans Affairs Medical Center and Assistant Professor at George Washington University, Dr. Rachel Denyer who will present the following publication for discussion:
Dr. Denyer will provide a 15-20 minute synopsis of the publication. Two respondents from different disciplines will then provide their perspectives for 5-10 minutes. Dr. Ali Talan (WW) will respond to this article from a Social and Behavioral Sciences perspective and Dr. Preethi Chandran (HU) will respond to this article from a Basic Sciences perspective. An open discussion will follow the presentations to hopefully discover opportunities for possible collaborations on future research initiatives.
|
|
Training Program in Approaches to Address Social-Structural Factors Related to HIV Intersectionally (TASHI) |
The George Washington University (GWU) has a newly funded NIMH T32, Training Program in Approaches to Address Social-Structural Factors Related to HIV Intersectionally (TASHI). The program is offering full doctoral scholarships (tuition, living expenses, and health insurance) to prepare the next generation of community-engaged researchers to develop and lead social-structural and intersectional approaches to promote equity and improve HIV and related health outcomes. The training program is supported by 18 multi-disciplinary faculty conducting both global and domestic research on HIV, mental health, substance use, and violence. Trainees will receive instruction and mentorship in the following:
- Social and structural, critical, and intersectional theory
- Community-engaged research design and methods
- Multi-level intervention development and evaluation
- Grant writing, publication and presentation skills
Please note that trainees must apply and be accepted into one of three PhD programs at GWU: Social and Behavioral Sciences in the Department of Prevention and Community Health, in the Milken Institute School of Public Health or Clinical Psychology or Applied Social Psychology in the Department of Psychological and Brain Sciences in the Columbian College of Arts and Sciences. Individuals from underrepresented populations are strongly encouraged to apply.
|
|
|
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. |
|
DC CFAR partner institutions and community-based organizations have developed numerous excellent COVID-19 resources. We've included a collection of these here, along with a number of other opportunities for your reference. We will continue to update these resources in the days ahead and we encourage you to send information that may be of interest to our DC CFAR community to CFARinDC@gmail.com.
|
|
September 15, 2022
September 16, 2022
September 22, 2022
September 22, 2022
September 30, 2022
October 6, 2022
Miami, FL
October 7, 2022
October 8-11, 2022
San Juan, PR
October 13-14, 2022
October 24-26, 2022
November 7-9, 2022
November 15-18, 2022
Abstracts due September 30th
November 14, 2022
November 14-18, 2022
December 13-16, 2022
February 19-22, 2023
Seattle, Washington
Abstracts due September 20, 2022
For more DC CFAR events please see the calendar here.
|
|
FUNDING, TRAINING AND MENTORING OPPORTUNITIES
|
|
PCORI released new funding announcements soliciting comparative clinical effectiveness research (CER) projects on high-priority topics, studies on how to improve the methods used to conduct patient-centered CER, and projects to implement results into practice. Letters of intent are due Oct. 4.
This HIV prevention study at Whitman Walker Health is currently recruiting. For more information please click here.
The African Academy of Sciences (AAS), in partnership with the U.S. National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation (BMGF), announces a call for applications for the 3rd cohort of the African Postdoctoral Training Initiative (APTI) fellowships. APTI Fellows are trained and supported to become scientific leaders who can advocate for increased research and innovation projects in Africa.
The National Institute on Drug Abuse released the Racial Equity Initiative to organize the Institute’s efforts to eliminate racism in NIDA’s workplace, scientific workforce, and research portfolio. Including a number of funding opportunities here.
The National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Mental Health (NIMH) released a Notice of Special Interest (NOSI) to identify new opportunities for cure interventions administered during active HIV infection at or near the start of antiretroviral therapy (ART) or as a potential replacement for conventional ART, with the ultimate goal of achieving a sustained ART-free HIV remission.
|
|
NIH FUNDING OPPORTUNITIES
|
|
Funding Opportunity Number: PAR-22-204
Posting Date: September 9, 2022
Closing Date: January 7, 2023
Funding Opportunity Number: PAR-23-024
Posting Date: August 25, 2022
Closing Date: May 1, 2023
Funding Opportunity Number: PAR-22-223
Posting Date: August 9, 2022
Closing Date: December 7, 2022
Funding Opportunity Number: PAR-22-222
Posting Date: August 4, 2022
Closing Date: December 7, 2022
Funding Opportunity Number: RFA-HD-23-013
Posting Date: July 22, 2022
Closing Date: December 6, 2022
Funding Opportunity Number: RFA-MH-22-191
Posting Date: July 20, 2022
Closing Date: November 18, 2022
Click here for additional funding opportunities available from the National Institutes of Health.
|
|
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
|
|
|
|
|
|
|
